We're sorry but this page doesn't work properly without JavaScript enabled. Please enable it to continue.
Feedback

Microbial Drug Resistance

Formal Metadata

Title
Microbial Drug Resistance
Title of Series
Number of Parts
340
Author
License
CC Attribution - NonCommercial - NoDerivatives 4.0 International:
You are free to use, copy, distribute and transmit the work or content in unchanged form for any legal and non-commercial purpose as long as the work is attributed to the author in the manner specified by the author or licensor.
Identifiers
Publisher
Release Date
Language

Content Metadata

Subject Area
Genre
Abstract
In 2011, 1.4 million people died from tuberculosis, and Mycobacterium tuberculosis is now the second greatest killer of mankind by a single infectious agent, surpassed only by HIV/AIDS. A further 7.3 million have been diagnosed with the active form of the disease, and a third of the world’s population, now in excess of 7 billion, has been estimated to have a latent TB infection, and to be at risk of progressing to the active disease. Today, multi-drug resistant tuberculosis, extensively drug-resistant tuberculosis, and totally resistant tuberculosis add to the difficulties of treating the disease. In 2015, multidrug-resistant TB strains of M. tuberculosis caused an estimated 480,000 new cases of TB and 250,000 deaths. The lecture will discuss approaches to dealing with this growing threat to mankind.